Safety of a Novel Gel Formulation of Clindamycin Phosphate 1.2%–Tretinoin 0.025%: Results From a 52-Week Open-Label Study

Article Type
Changed
Thu, 01/10/2019 - 12:16
Display Headline
Safety of a Novel Gel Formulation of Clindamycin Phosphate 1.2%–Tretinoin 0.025%: Results From a 52-Week Open-Label Study

Article PDF
Author and Disclosure Information

Kircik LH, Peredo MI, Bucko AD, Loss RW Jr, Fowler JF Jr, Wortzman M, Neumaier GJ

Issue
Cutis - 82(5)
Publications
Topics
Page Number
358-366
Sections
Author and Disclosure Information

Kircik LH, Peredo MI, Bucko AD, Loss RW Jr, Fowler JF Jr, Wortzman M, Neumaier GJ

Author and Disclosure Information

Kircik LH, Peredo MI, Bucko AD, Loss RW Jr, Fowler JF Jr, Wortzman M, Neumaier GJ

Article PDF
Article PDF

Issue
Cutis - 82(5)
Issue
Cutis - 82(5)
Page Number
358-366
Page Number
358-366
Publications
Publications
Topics
Article Type
Display Headline
Safety of a Novel Gel Formulation of Clindamycin Phosphate 1.2%–Tretinoin 0.025%: Results From a 52-Week Open-Label Study
Display Headline
Safety of a Novel Gel Formulation of Clindamycin Phosphate 1.2%–Tretinoin 0.025%: Results From a 52-Week Open-Label Study
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media